Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
MCL1 is essential for the survival of stem and progenitor cells of multiple lineages, and is unique among pro-survival BCL2 family members in that it is rapidly turned over through the action of ubiquitin ligases. B- and mantle-cell lymphomas, chronic myeloid leukaemia, and multiple myeloma, however, express abnormally high levels of MCL1, contributing to chemoresistance and disease relapse. The mechanism of MCL1 overexpression in cancer is not well understood. Here we show that the deubiquitinase USP9X stabilizes MCL1 and thereby promotes cell survival. USP9X binds MCL1 and removes the Lys 48-linked polyubiquitin chains that normally mark MCL1 for proteasomal degradation. Increased USP9X expression correlates with increased MCL1 protein in human follicular lymphomas and diffuse large B-cell lymphomas. Moreover, patients with multiple myeloma overexpressing USP9X have a poor prognosis. Knockdown of USP9X increases MCL1 polyubiquitination, which enhances MCL1 turnover and cell killing by the BH3 mimetic ABT-737. These results identify USP9X as a prognostic and therapeutic target, and they show that deubiquitinases may stabilize labile oncoproteins in human malignancies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Phosphorylation of MCL1 at S159 and T163 also affects the USP9X-MCL1 interaction [121].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [121]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis
Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., & Tanaka, †. N. (2000) · Science · doi:10.1126/science.288.5468.1053 · Cited by 2,112
van Delft, M. F., Wei, A. H., Mason, K. D., Vandenberg, C. J., Chen, L., Czabotar, P. E., Willis, S. N., Scott, C. L., Day, C. L., Cory, S., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.027 · Cited by 1,240
Self-citationThe molecular classification of multiple myeloma
Zhan, F., Huang, Y., Colla, S., Stewart, J. P., Hanamura, I., Gupta, S., Epstein, J., Yaccoby, S., Sawyer, J., Burington, B., et al. (2006) · Blood · doi:10.1182/blood-2005-11-013458 · Cited by 1,133
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling
Hummel, M., Bentink, S., Berger, H., Klapper, W., Wessendorf, S., Barth, T. F. E., Bernd, H.-W., Cogliatti, S. B., Dierlamm, J., Feller, A. C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055351 · Cited by 1,006
Maurer, U., Charvet, C., Wagman, A. S., Dejardin, E., & Green, D. R. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.02.009 · Cited by 881
Zhong, Q., Gao, W., Du, F., & Wang, X. (2005) · Cell · doi:10.1016/j.cell.2005.06.009 · Cited by 842
Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1
Opferman, J. T., Letai, A., Beard, C., Sorcinelli, M. D., Ong, C. C., & Korsmeyer, S. J. (2003) · Nature · doi:10.1038/nature02067 · Cited by 801
Cited by
Items 401–500 of 630
Aberrant expression of deubiquitylating enzyme USP9X predicts poor prognosis in gastric cancer
Fu, X., Xie, W., Song, X., Wu, K., Xiao, L., Liu, Y., & Zhang, L. (2017) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2017.01.008 · Cited by 21
Kang, M., Yun, H. H., & Lee, J. H. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.08.118 · Cited by 21
Phosphatase PP2A enhances MCL-1 protein half-life in multiple myeloma cells
Slomp, A., Moesbergen, L. M., Eldering, E., Kersten, M. J., Minnema, M. C., & Peperzak, V. (2021) · Cell Death and Disease · doi:10.1038/s41419-020-03351-7 · Cited by 22
TAK1–JNK Axis Mediates Survival Signal through Mcl1 Stabilization in Activated T Cells
Hirata, Y., Sugie, A., Matsuda, A., Matsuda, S., & Koyasu, S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202809 · Cited by 21
Acetylation: a new target for protein degradation in cancer
Crawford, C. E. W., & Burslem, G. M. (2025) · Trends in Cancer · doi:10.1016/j.trecan.2025.01.013 · Cited by 20
Trial Watch: Proteasomal inhibitors for anticancer therapy
Obrist, F., Manic, G., Kroemer, G., Vitale, I., & Galluzzi, L. (2014) · Molecular & Cellular Oncology · doi:10.4161/23723556.2014.974463 · Cited by 23
Nifoussi, S. K., Ratcliffe, N. R., Ornstein, D. L., Kasof, G. M., Strack, S., & Craig, R. W. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.587873 · Cited by 22
Yang, P., Xie, J., Li, Y., Lin, H.-P., Fenske, W., Clementino, M., Jiang, Y., Yang, C., & Wang, Z. (2020) · Theranostics · doi:10.7150/thno.47897 · Cited by 20
Wensveen, F. M., van Gisbergen, K. P. J. M., & Eldering, E. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01156.x · Cited by 21
Systematic Identification and Analysis of Lysine Succinylation in Strawberry Stigmata
Fang, X., Xin, Y., Sheng, Z., Liu, H., Jiang, A., Wang, F., Yang, J., Xi, X., Zha, Q., Zhang, L., et al. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b02708 · Cited by 20
Ubiquitin system mutations in neurological diseases
Zenge, C., & Ordureau, A. (2024) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2024.06.011 · Cited by 20
The deubiquitinase Usp9x regulates PRC2-mediated chromatin reprogramming during mouse development
Macrae, T. A., & Ramalho‐Santos, M. (2021) · Nature Communications · doi:10.1038/s41467-021-21910-0 · Cited by 16
Mitochondrial proteotoxicity: implications and ubiquitin-dependent quality control mechanisms
Karbowski, M., Oshima, Y., & Verhoeven, N. A. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04604-8 · Cited by 23
Identification of a Deubiquitinating Enzyme as a Novel AGS3-Interacting Protein
Xu, Z., Xia, B., Gong, Q., Bailey, J., Groves, B., Radeke, M. J., Wood, S. A., Szumlinski, K. K., & Ma, D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009725 · Cited by 19
Zhang, J., Wang, J., Luan, T., Zuo, Y., Chen, J., Zhang, H., Ye, Z., Wang, H., & Hai, B. (2019) · Oncology Reports · doi:10.3892/or.2019.7131 · Cited by 22
Dual Inhibition of Bcl-2/Bcl-xL and XPO1 is synthetically lethal in glioblastoma model systems
Shang, E., Zhang, Y., Shu, C., Ishida, C. T., Bianchetti, E., Westhoff, M., Karpel‐Massler, G., & Siegelin, M. D. (2018) · Scientific Reports · doi:10.1038/s41598-018-33784-2 · Cited by 19
Ubiquitination Enzymes in Cancer, Cancer Immune Evasion, and Potential Therapeutic Opportunities
Awan, A. B., Osman, M. J. A., & Khan, O. M. (2025) · Cells · doi:10.3390/cells14020069 · Cited by 25
Deubiquitinase USP9X controls Wnt signaling for CNS vascular formation and barrier maintenance
Lei, Y., Hu, J., Zhao, J., Liu, Q., Zhang, S. W., Wu, F., Liu, Y., Ren, H., Qin, X., Wu, X., et al. (2025) · Developmental Cell · doi:10.1016/j.devcel.2025.01.009 · Cited by 20
Deubiquitinating Enzymes: A Critical Regulator of Mitosis
Park, J., Cho, J., Kim, E. E., & Song, E. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235997 · Cited by 21
The role of post-translational modifications in the regulation of MCL1
Li, S., Guo, W., & Wu, H. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.109933 · Cited by 29
The role of ubiquitin-specific peptidases in glioma progression
Liang, W., Fang, J., Zhou, S., Hu, W., Yang, Z., Li, Z., Dai, L., Tao, Y., Fu, X., & Wang, X. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112585 · Cited by 19
The Emerging Role of Deubiquitinases in Cell Death
Zhou, Z., Song, X., Kang, R., & Tang, D. (2022) · Biomolecules · doi:10.3390/biom12121825 · Cited by 21
Wang, P., Wang, J., Yao, S., Cui, M., Cheng, Y., Liu, W., Gao, Z., Hu, J. J., Zhang, J., & Zhang, H. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105055 · Cited by 18
ATP-driven processes of peroxisomal matrix protein import
Schwerter, D., Grimm, I., Platta, H. W., & Erdmann, R. (2016) · Biological Chemistry · doi:10.1515/hsz-2016-0293 · Cited by 23
Sulkshane, P., & Teni, T. R. (2022) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2022.00083 · Cited by 22
Perciavalle, R. M. (2012) · doi:10.21007/etd.cghs.2012.0242 · Cited by 18
Fonseca, R., Zhu, Y. X., Bruins, L. A., Ahmann, J., de Campos, C. B., Braggio, E., Chen, X., Arribas, M., Darvish, S. A., Welsh, S. J., et al. (2025) · Blood Cancer Journal · doi:10.1038/s41408-025-01215-x · Cited by 18
Akiyama, H., Umezawa, Y., Watanabe, D., Okada, K., Ishida, S., Nogami, A., & Miura, O. (2020) · Cancers · doi:10.3390/cancers12020406 · Cited by 17
Goodall, K. J., Finch‐Edmondson, M., van Vuuren, J., Yeoh, G. C., Gentle, I. E., Vince, J. E., Ekert, P. G., Vaux, D. L., & Callus, B. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164003 · Cited by 18
Counting on Death – Quantitative aspects of Bcl‐2 family regulation
Hantusch, A., Rehm, M., & Brunner, T. (2018) · FEBS Journal · doi:10.1111/febs.14516 · Cited by 20
Hlaváč, M., Dwucet, A., Kast, R. E., Engelke, J., Westhoff, M., Siegelin, M. D., Debatin, K., Wirtz, C. R., Halatsch, M., & Karpel‐Massler, G. (2019) · Cellular Oncology · doi:10.1007/s13402-019-00425-3 · Cited by 17
SUMOylation of MCL1 protein enhances its stability by regulating the ubiquitin-proteasome pathway
Li, S., Wang, J., Hu, G., Aman, S., Li, B., Li, Y., Xia, K., Yang, Y., Ahmad, B., Wang, M., et al. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109686 · Cited by 17
Prophylactic treatment with the BH3 mimetic ABT-737 impedes Myc-driven lymphomagenesis in mice
Kelly, P. N., Grabow, S., Delbridge, A. R. D., Adams, J. M., & Strasser, A. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.92 · Cited by 17
Structural Basis of Substrate Recognition and Covalent Inhibition of Cdu1 from Chlamydia trachomatis
Ramírez, Y. A., Adler, T. B., Altmann, E., Klemm, T., Tiesmeyer, C., Sauer, F., Kathman, S. G., Statsyuk, A. V., Sotriffer, C., & Kisker, C. (2018) · ChemMedChem · doi:10.1002/cmdc.201800364 · Cited by 18
Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics
Chen, X., Lu, D., Gao, J., Zhu, H., Zhou, Y., Gao, D., & Zhou, H. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00139 · Cited by 16
Shanbhag, R., Shi, G., Rujiviphat, J., & McQuibban, G. A. (2012) · Parkinson s Disease · doi:10.1155/2012/382175 · Cited by 18
Furuta, H., Yoshihara, H., Fukushima, T., Yoneyama, Y., Ito, A., Worrall, C., Girnita, A., Girnita, L., Yoshida, M., Asano, T., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.26049 · Cited by 15
Beverly, L. J. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23335 · Cited by 17
Molecular Pathways: Turning Proteasomal Protein Degradation into a Unique Treatment Approach
Stintzing, S., & Lenz, H. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3175 · Cited by 17
Min, K., Um, H. J., Kim, J. I., & Kwon, T. K. (2017) · Oncotarget · doi:10.18632/oncotarget.20541 · Cited by 16
Usp9X Regulates Cell Death in Malignant Peripheral Nerve Sheath Tumors
Bianchetti, E., Bates, S. J., Carroll, S. L., Siegelin, M. D., & Roth, K. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-35806-5 · Cited by 16
Nakajima, W., & Tanaka, N. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.09.036 · Cited by 18
USP36 inhibits apoptosis by deubiquitinating cIAP1 and survivin in colorectal cancer cells
Gao, B. J., Qiao, Y., Zhu, S., Yang, N., Zou, S.-S., Liu, Y., & Chen, J. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107463 · Cited by 20
Downregulation of SOX2 by inhibition of Usp9X induces apoptosis in melanoma
Potu, H., Kandarpa, M., Peterson, L. F., Durham, A. B., Donato, N. J., & Talpaz, M. (2021) · Oncotarget · doi:10.18632/oncotarget.27869 · Cited by 15
Degrasyn-like symmetrical compounds: Possible therapeutic agents for multiple myeloma (MM-I)
Peng, Z., Maxwell, D. S., Sun, D., Prasad, B. A. B., Schuber, P. T., Pal, A., Ying, Y., Han, D., Gao, L., Wang, S., et al. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.12.048 · Cited by 15
Zheng, W., Li, S., Huang, J., Dong, Y., Zhang, H., & Zheng, J. (2022) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b22-00198 · Cited by 15
Identification of USP9X as a leukemia susceptibility gene
Sisoudiya, S. D., Mishra, P., Li, H., Schraw, J. M., Scheurer, M. E., Salvi, S., Doddapaneni, H., Muzny, D. M., Mitchell, D., Taylor, O. A., et al. (2023) · Blood Advances · doi:10.1182/bloodadvances.2023009814 · Cited by 14
FBW7 in hematological tumors (Review)
Zhu, Q., Hu, L., Guo, Y., Xiao, Z., Xu, Q., & Tong, X. (2020) · Oncology Letters · doi:10.3892/ol.2020.11264 · Cited by 18
Ryu, Y., Hall, C. P., Reynolds, C. P., & Kang, M. H. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214538745 · Cited by 16
Kapadia, B. B., & Gartenhaus, R. B. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0307 · Cited by 14
Liang, R., Zhang, X., Zhao, J., Zhu, R., Wang, W., Lu, Q.-W., & Sun, Y. (2022) · Laboratory Investigation · doi:10.1038/s41374-022-00836-1 · Cited by 14
Perurena, N., Lock, R., Davis, R. A., Raghavan, S., Pilla, N. F., Ng, R. W. S., Loi, P., Guild, C. J., Miller, A. L., Sicińska, E., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101007 · Cited by 13
Tang, G. L. Q., Lai, J. X. H., & Pervaiz, S. (2023) · Haematologica · doi:10.3324/haematol.2023.283730 · Cited by 21
Wu, K., Woo, S. M., & Kwon, T. K. (2020) · Journal of Cancer Prevention · doi:10.15430/jcp.2020.25.2.79 · Cited by 13
Deubiquitinating Enzyme: A Potential Secondary Checkpoint of Cancer Immunity
Huang, X., Zhang, X., Xu, J., Wang, X., Zhang, G., Tang, T., Shen, X., Liang, T., & Bai, X. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01289 · Cited by 14
Self-citationLi, S., Zhang, H., & Wei, X. (2021) · Life · doi:10.3390/life11090965 · Cited by 14
Biomarkers of Therapeutic Response to BCL2 Antagonists in Cancer
Lam, L. T., Zhang, H., & Chyla, B. (2012) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-012-0003-6 · Cited by 13
Li, L., Wang, Y., Zhang, X., Song, G., Guo, Q., Zhang, Z., Diao, Y., Yin, H., Liu, H., & Jiang, G. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4440 · Cited by 18
PPPDE1 promotes hepatocellular carcinoma development by negatively regulate p53 and apoptosis
Xie, X., Wang, X., Liao, W., Fei, R., Wu, N., Xu, C., Chen, Q., Wei, L., Wang, Y., & Chen, H. (2018) · APOPTOSIS · doi:10.1007/s10495-018-1491-6 · Cited by 14
MCL1 as a Therapeutic Target in Parkinson's Disease?
Robinson, E. J., Aguiar, S. P., Smidt, M. P., & van der Heide, L. P. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.08.009 · Cited by 13
DDX3 interacts with USP9X and participates in deubiquitination of the anti‐apoptotic protein MCL1
Lai, M., Chen, Y., Li, D., Yu, J., Hung, H., & Tarn, W. (2021) · FEBS Journal · doi:10.1111/febs.16219 · Cited by 15
Mouse Noxa uses only the C-terminal BH3-domain to inactivate Mcl-1
Weber, A., Ausländer, D., & Häcker, G. A. (2013) · APOPTOSIS · doi:10.1007/s10495-013-0868-9 · Cited by 12
Li, H., & Zheng, B. (2019) · Medical Science Monitor · doi:10.12659/msm.914742 · Cited by 12
Global Identification and Systematic Analysis of Lysine Malonylation in Maize (Zea mays L.)
Xu, M., Tian, X., Ku, T., Wang, G., & Zhang, E. (2021) · Frontiers in Plant Science · doi:10.3389/fpls.2021.728338 · Cited by 12
Eriksson, P., Aine, M., Sjödahl, G., Staaf, J., Lindgren, D., & Höglund, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067222 · Cited by 13
A novel Mcl1 variant inhibits apoptosis via increased Bim sequestration
Hagenbuchner, J., Kiechl‐Kohlendorfer, U., Obexer, P., & Ausserlechner, M. J. (2013) · Oncotarget · doi:10.18632/oncotarget.1147 · Cited by 13
Aqaqe, N., Yassin, M., Yassin, A. A., Ershaid, N., Katz-Even, C., Zipin‐Roitman, A., Kugler, E., Lechman, E. R., Gan, O. I., Mitchell, A., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3215 · Cited by 13
The Role of Deubiquitinating Enzyme in Head and Neck Squamous Cell Carcinoma
Jin, S., Kudo, Y., & Horiguchi, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010552 · Cited by 14
Fine tuning of the transcription juggernaut: A sweet and sour saga of acetylation and ubiquitination
Ghosh, A., Chakraborty, P., & Biswas, D. (2023) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2023.194944 · Cited by 12
Song, N., Deng, L., Zeng, L., Li, H., Liu, C., Liu, L., & Fu, R. (2023) · Molecular Carcinogenesis · doi:10.1002/mc.23591 · Cited by 11
Non-canonical regulation of homologous recombination DNA repair by the USP9X deubiquitylase
O'Dea, R., & Santocanale, C. (2020) · Journal of Cell Science · doi:10.1242/jcs.233437 · Cited by 13
Deubiquitinating enzyme USP41 promotes lung cancer cell proliferation and migration
Ji, J., Yang, S., Zu, L., Li, Y., & Li, Y. (2021) · Thoracic Cancer · doi:10.1111/1759-7714.13843 · Cited by 13
Wu, H., Chen, Z., Wu, Y., Zhang, H., & Liu, Q. (2021) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-021-00475-y · Cited by 13
USP9X Is Required to Maintain Cell Survival in Response to High-LET Radiation
Nickson, C. M., Fabbrizi, M. R., Carter, R. J., Hughes, J. R., Kacperek, A., Hill, M. A., & Parsons, J. L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.671431 · Cited by 12
Stalling in mitosis and releasing the apoptotic brake
Kurokawa, M., & Kornbluth, S. A. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.150 · Cited by 11
Biber, P., Carminati, A., Mohager, W., Ohanna, M., Girard, C. A. J., Lecacheur, M., Kahil, M., Bouvet, O., Irondelle, M., Audebert, S., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116372 · Cited by 11
Li, X., Li, W., Zhang, Y., Xu, L., & Song, Y. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.101150 · Cited by 12
Regulation of apoptosis by ubiquitination in liver cancer.
Li, Y., Zhu, J., Yu, Z., Zhai, F., Li, H., & Jin, X. (2023) · PubMed Central · Cited by 16
The deubiquitinating enzyme USP20 regulates the stability of the MCL1 protein
Feng, J., Liu, P., Li, X., Zhang, D., Lin, H., Hou, Z., Guo, C., Niu, Y., Dai, B., Wang, O., et al. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.01.019 · Cited by 12
Targeting deubiquitinases for cancer therapy
Xue, Q., Tang, D., Chen, X., & Liu, J. (2023) · Clinical and Translational Discovery · doi:10.1002/ctd2.242 · Cited by 14
Self-citationDUB-le Trouble for Cell Survival
Opferman, J. T., & Green, D. R. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.011 · Cited by 11
Cell death in cancer in the era of precision medicine
Raschellà, G., Melino, G., & Gambacurta, A. (2018) · Genes and Immunity · doi:10.1038/s41435-018-0048-6 · Cited by 11
Takano, T., Kohara, M., Kasama, Y., Nishimura, T., Saito, M., Kai, C., & Tsukiyama–Kohara, K. (2011) · Journal of Medical Virology · doi:10.1002/jmv.22046 · Cited by 10
Isopeptidases in anticancer therapy: looking for inhibitors.
Sgorbissa, A., Potu, H., & Brancolini, C. (2010) · PubMed · Cited by 9
Ozfiliz-Kilbas, P., Arısan, E. D., Gürkan, A. Ç., Yerlikaya, P. O., Eralp, T. N., Doğanay, G. D., & Palavan-Ünsal, N. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.11.4475 · Cited by 9
Measurement of Deubiquitinating Enzyme Activity Via a Suicidal HA-Ub-VS Probe
Rivard, C. L., & Bazzaro, M. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-2013-6_14 · Cited by 9
Chronic myeloid leukemia stem cells and developing therapies
Donato, N. J., & Peterson, L. F. (2011) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2010.546921 · Cited by 8
Mcl1 becomes ubiquitin-ous: new opportunities to antagonize a pro-survival protein
Hogarty, M. D. (2010) · Cell Research · doi:10.1038/cr.2010.37 · Cited by 8
USP9X suppresses ferroptosis in diabetic kidney disease by deubiquitinating Nrf2 in vitro
Shao, N., Cai, K., Hong, Y., Wu, L., & Luo, Q. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2458761 · Cited by 8
The VTLISFG motif in the BH1 domain plays a significant role in regulating the degradation of Mcl‐1
Xiao, K., Chen, P., & Chang, D. C. (2014) · FEBS Open Bio · doi:10.1016/j.fob.2014.01.006 · Cited by 9
Xiufeng, Z., Haijun, Z., Bi, S., Manman, D., Zhou, Y., Yu, L., Zhihong, F., & Xu, B. (2018) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000702 · Cited by 8
Yang, L., Wang, S., Pan, Z., Du, X., & Li, Q. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30776 · Cited by 9
HU, H., Tang, C., Jiang, Q., LUO, W., LIU, J., Wei, X., Liu, R., & Wu, Z. (2015) · Oncology Letters · doi:10.3892/ol.2015.3152 · Cited by 9
Self-citationDUB-ling down on B-cell malignancies
Boise, L. (2015) · Blood · doi:10.1182/blood-2015-04-638262 · Cited by 8
Chen, W., Shan, Y., Wang, M., Liang, R., & Sa, R. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17354 · Cited by 12
Anti-apoptotic BCL-2 family proteins: from regulatory networks to therapeutic targeting
Wang, Z., Tang, M., & Konopleva, M. (2026) · Oncogenesis · doi:10.1038/s41389-026-00632-2 · Cited by 12
Wang, C.-C., Liu, H. E., Lee, Y., Huang, Y.-W., Chen, Y., Liou, J., & Huang, H.-M. (2015) · Tumor Biology · doi:10.1007/s13277-015-4380-4 · Cited by 7
Protein destabilization and degradation as a mechanism for hereditary disease
Nielsen, S. V., Schenstrøm, S. M., Christensen, C. E., Stein, A., Lindorff‐Larsen, K., & Hartmann‐Petersen, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819132-3.00006-3 · Cited by 8
Tian, T., Bi, H., Liu, Y., Li, G., Zhang, Y., Cao, L., Hu, F., Zhao, Y., & Yuan, H. (2020) · Cancer Biology & Therapy · doi:10.1080/15384047.2020.1750860 · Cited by 7
Noh, M., Zhang, H., Kim, H., Park, S., Kim, Y., & Kwon, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.695009 · Cited by 7
Metadata
- Authors
- Schwickart, M., Huang, X., Lill, J. R., Liu, J., Ferrando, R., French, D. M., Maecker, H., O’Rourke, K., Bazan, F., Eastham-Anderson, J., Yue, P., Dornan, D., Huang, D. C. S., & Dixit, V. M.
- Affiliations
- Genentech (US)
- Walter and Eliza Hall Institute of Medical Research (AU)
- Corresponding author
- Dixit, Vishva M.
- Venue
- Nature
- Published
- 2009-12-20
- Volume
- 463
- Issue
- 7277
- Pages
- 103-107
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1991249033
- Cited by
- 628
- References
- 31
- Citations by year
- 2026: 18 · 2025: 21 · 2024: 20 · 2023: 21 · 2022: 20 · 2021: 38 · 2020: 41 · 2019: 44 · 2018: 45 · 2017: 45 · 2016: 51 · 2015: 49 · 2014: 50 · 2013: 46 · 2012: 44
- FWCI
- 15.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Keywords
- USP9X, Mcl-1, deubiquitinase, protein stabilization, ubiquitination, multiple myeloma, Bcl-2 family proteins, apoptosis, ABT-737, BH3 mimetics, follicular lymphoma, diffuse large B-cell lymphoma, chemoresistance, therapeutic target, prognosis, proteasomal degradation, stem/progenitor cells, tumor cell survival
- MeSH terms
- Docetaxel, Animals, Biphenyl Compounds, Cell Line, Cell Survival, DNA Damage, Etoposide, Female, Half-Life, Humans, Lysine, Neoplasms, Nitrophenols, Phosphorylation, Piperazines, Prognosis, Protein Binding, Sulfonamides, Ultraviolet Rays, Gene Expression Regulation, Neoplastic, Mice, SCID, Apoptosis, Proto-Oncogene Proteins c-bcl-2, Xenograft Model Antitumor Assays, Polyubiquitin, RNA Interference, Ubiquitin Thiolesterase, Taxoids, Cell Line, Tumor, Mice, Ubiquitination, Protein Stability, Gene Knockdown Techniques, Myeloid Cell Leukemia Sequence 1 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.